(Q58459182)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Complex karyotype and translocation t(4;14) define patients with high-risk newly diagnosed multiple myeloma: results of CMG2002 trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Kyra Michalová

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Martina Hrubá

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Ivan Špička

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Roman Hajek

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Pavel Nemec

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Petr Kuglik

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Jana Tajtlova

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Petra Kaisarova

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Alexandra Oltova

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Hana Filkova

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Milena Holzerova

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Jana Balcarkova

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Marie Jarosova

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Jana Rabasova

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Evzen Gregora

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Zdenek Adam

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Vlastimil Scudla

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Vladimir Maisnar

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Miroslava Schutzova

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Czech Myeloma Group

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

13 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

920-927

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

Molecular pathogenesis and a consequent classification of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transpla

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

Gain of 1q21 is an unfavorable genetic prognostic factor for multiple myeloma patients treated with high-dose chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

International uniform response criteria for multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

Clinical and biologic implications of recurrent genomic aberrations in myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

Amplification and overexpression of CKS1B at chromosome band 1q21 is associated with reduced levels of p27Kip1 and an aggressive clinical course in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH/MMSET fusion transcript

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy II.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

p53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

Influence of cytogenetics in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone: adverse effect of deletion 17p13.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

Clinical factors predictive of outcome with bortezomib in patients with relapsed, refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

Bortezomib in relapsed multiple myeloma: response rates and duration of response are independent of a chromosome 13q-deletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.634042

10.3109/10428194.2011.634042

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22023516%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference